Cardinal Health, Inc. $CAH Shares Bought by Dimensional Fund Advisors LP

Key Points

• Dimensional Fund Advisors LP increased its position in Cardinal Health by 0.6%, acquiring an additional 7,940 shares during the first quarter, bringing its total ownership to over 1.24 million shares valued at approximately $171.7 million.
• Insiders at Cardinal Health have significantly reduced their holdings, with over 235,000 shares sold in the last 90 days, indicating potential shifts in management confidence or strategy.
• Cardinal Health reported earnings per share of $2.08 for the last quarter, exceeding expectations, even as its yearly revenue showed only a 0.5% increase compared to the previous year.

Dimensional Fund Advisors LP increased its stake in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 0.6% during the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,246,788 shares of the company's stock after buying an additional 7,940 shares during the quarter. Dimensional Fund Advisors LP owned about 0.52% of Cardinal Health worth $171,749,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CAH. Greykasell Wealth Strategies Inc. acquired a new position in shares of Cardinal Health during the 1st quarter valued at about $26,000. Tompkins Financial Corp boosted its holdings in Cardinal Health by 106.7% in the 1st quarter. Tompkins Financial Corp now owns 248 shares of the company's stock valued at $34,000 after purchasing an additional 128 shares during the last quarter. Bellwether Advisors LLC purchased a new stake in shares of Cardinal Health in the 4th quarter valued at approximately $32,000. GW&K Investment Management LLC increased its holdings in shares of Cardinal Health by 113.4% during the 1st quarter. GW&K Investment Management LLC now owns 271 shares of the company's stock worth $37,000 after buying an additional 144 shares during the last quarter. Finally, Itau Unibanco Holding S.A. acquired a new stake in shares of Cardinal Health during the 4th quarter worth approximately $36,000. Institutional investors and hedge funds own 87.17% of the company's stock.

Cardinal Health Stock Down 0.7%

NYSE CAH traded down $1.0430 during trading hours on Monday, hitting $147.0570. 207,049 shares of the company were exchanged, compared to its average volume of 2,411,024. The firm has a market cap of $35.12 billion, a price-to-earnings ratio of 22.82, a PEG ratio of 1.25 and a beta of 0.67. The company has a 50 day moving average of $159.02 and a two-hundred day moving average of $145.58. Cardinal Health, Inc. has a 52-week low of $106.54 and a 52-week high of $168.44.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.03 by $0.05. The business had revenue of $60.16 billion during the quarter, compared to analysts' expectations of $60.91 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The business's quarterly revenue was up .5% compared to the same quarter last year. During the same quarter last year, the business posted $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, equities research analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be issued a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date of this dividend is Wednesday, October 1st. Cardinal Health's payout ratio is 31.63%.

Insider Activity at Cardinal Health

In other news, insider Ola M. Snow sold 28,151 shares of the company's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the completion of the transaction, the insider directly owned 15,431 shares of the company's stock, valued at approximately $2,298,293.14. This represents a 64.59% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Jessica L. Mayer sold 38,078 shares of the firm's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $5,666,767.96. Following the sale, the insider directly owned 48,457 shares in the company, valued at $7,211,370.74. This trade represents a 44.00% decrease in their position. The disclosure for this sale can be found here. Insiders sold 271,676 shares of company stock worth $40,489,525 over the last three months. Company insiders own 0.09% of the company's stock.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on the company. Bank of America increased their price objective on Cardinal Health from $165.00 to $170.00 and gave the stock a "buy" rating in a research report on Tuesday, June 10th. Wells Fargo & Company reissued an "overweight" rating and set a $185.00 price objective (up from $183.00) on shares of Cardinal Health in a research report on Wednesday, August 13th. Morgan Stanley restated an "overweight" rating on shares of Cardinal Health in a report on Tuesday, August 12th. Leerink Partners lowered their target price on shares of Cardinal Health from $188.00 to $186.00 and set an "outperform" rating for the company in a research note on Tuesday, August 12th. Finally, Wall Street Zen cut shares of Cardinal Health from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 2nd. Twelve analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $163.20.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.